About this raise
OsNovum, with a valuation of $19.53 million, is raising funds on Wefunder. The company has developed a patented technology to regenerate bones affected by osteoporosis. OsNovum’s technology aims to improve skeletal health and improve the lifespan and quality of life. The technology has already been cleared by the FDA for maxillofacial use and waiting for clearance for skeletal use. The company plans to launch specialty clinics based on its technology. Gregory Steiner and Roslynn Steiner founded OsNovum in June 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $124,000. The campaign proceeds will be used for FDA tests, ISO certification, regulatory submissions, legal fees, capital improvements, production equipment, and salaries.
Investment Overview
Committed : $129,450
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 06/17/2024
- Close Date
- 04/30/2026
$50,000
$124,000
$100
Equity - Preferred
Early Stage
RegCF
$40.00
$19,532,200
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- High
Financials
-
Revenue
-
$5
as of FY2024
- Monthly Burn
-
$1,000
as of FY2024
-
Runway
-
0.1 months
as of
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $209,255
- VC Backed?
- No
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
